Avanos Medical Inc. (AVNS)
15.82
0.02 (0.13%)
At close: Jan 14, 2025, 3:59 PM
15.83
0.06%
After-hours Jan 14, 2025, 07:00 PM EST
undefined% (undefined)
| Bid | 6.34 |
| Market Cap | 727.04M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0.47 |
| PE Ratio (ttm) | 33.66 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 18.42 |
| Volume | 268,675 |
| Avg. Volume (20D) | 371,529 |
| Open | 15.88 |
| Previous Close | 15.80 |
| Day's Range | 15.50 - 15.94 |
| 52-Week Range | 14.98 - 25.36 |
| Beta | undefined |
About AVNS
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed ai...
Industry Medical - Devices
Sector Healthcare
IPO Date Oct 21, 2014
Employees 3,771
Stock Exchange NYSE
Ticker Symbol AVNS
Website https://avanos.com
Analyst Forecast
According to 1 analyst ratings, the average rating for AVNS stock is "Hold." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Buy 0.00%
Hold 100.00%
Sell 0.00%
Next Earnings Release
Avanos Medical Inc. is scheduled to release its earnings on Feb 18, 2025,
before market opens.
Analysts project revenue of $177.23M, reflecting a 2.27% YoY growth and earnings per share of 0.4, making a 11.11% increase YoY.
Analysts project revenue of $177.23M, reflecting a 2.27% YoY growth and earnings per share of 0.4, making a 11.11% increase YoY.
2 months ago ·
Source
-17.9%
Avanos Medical shares are trading lower after the ...
Unlock content with
Pro Subscription
5 months ago ·
Source
+4.18%
Avanos Medical shares are trading higher after the company reported better-than-expected Q2 financial results.
